The Neuromuscular Disease Program at Stony Brook involves a multidisciplinary approach to patients with Amyotrophic Lateral Sclerosis (ALS); commonly known as Lou Gehrigs Disease, which is supported by the ALS Association Greater New York Chapter. The Program also sees patients for diagnosis and treatment of:
- peripheral neuropathies
- myopathies
- myasthenia gravis
- muscular dystrophy
EMG and Nerve Conduction testing is also done at the Center as well as Single Fiber EMG's, Botox therapy, Autonomic Reflex testing. Outpatient muscle, nerve and skin biopsies are also performed.